吸入可以改善患有喘的小鼠的肺炎
Hongchang Li1, Xia Qi1, Hongyan Xu1
1Qingdao Special Servicemen Recuperation Center of PLA Navy, Qingdao, 266071, Shandong Province, China.
European journal of medical research
|October 28, 2025
概括
在喘小鼠模型中,吸入气有效降低了肺炎和呼吸道过敏反应. 这种抗氧化疗法对改善喘症状有前途,并可能提供一个可行的治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 喘是一种慢性呼吸道疾病,标志着II型炎症,呼吸道过敏反应和重塑.
- 具有已知的抗氧化和抗炎性质,对各种疾病有益.
研究的目的:
- 在小鼠模型中研究吸入气对卵胺 (OVA) 诱导的喘的治疗效果.
- 评估对肺炎,免疫反应和氧化应激标志物的影响.
主要方法:
- 小鼠被敏感化并用OVA挑战诱导喘模型.
- 作为治疗干预措施,气通过吸入连续七天进行了注射.
- 评估了呼吸道过敏反应,炎症性细胞因子水平 (IL-4,IL-5,IL-13,IL-10,TGF-β1),IgE,MDA,SOD和肺组织学.
主要成果:
- 吸入气显著降低了OVA诱导的气道过敏反应和肺炎.
- 通过降低IL-4,IL-5和IL-13水平减弱免疫反应.
- 增加了Treg相关的细胞因子 (IL-10,TGF-β1),降低了IgE和MDA,增加了SOD.
- 组织学分析显示,治疗小鼠的炎症细胞透和病理损伤明显减少.
结论:
- 在小鼠中,吸入能有效抑制了OVA诱导的喘.
- 在肺炎和氧化应激中显著改善.
- 建议吸入作为喘治疗的潜在可行和有效的治疗策略.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Inhaled Medications
728
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
728


